Reuptake
Top View
- Concerns Regarding Psychotropic Medications 1
- Drug Class Review Selective Serotonin Reuptake Inhibitors
- PED-1407 – Pediatric Mental Health
- Quantitative Analysis of Norepinephrine Transporter in the Human Brain Using PET with 18 (S,S)- F-Fmener-D2
- Pharmacologic Treatments in Major Depressive Disorder
- A Randomized Trial of an N-Methyl-D-Aspartate Antagonist in Treatment-Resistant Major Depression
- Serotonin and Norepinephrine Reuptake Inhibitors
- Serotonin-Dopamine Interactions in the Control of Conditioned Reinforcement and Motor Behavior Deanna M
- Serotonin Modulator Antidepressants
- Effects of the Selective Norepinephrine Reuptake Inhibitor Reboxetine on Norepinephrine and Serotonin Transmission in the Rat Hippocampus Steven T
- Trace Amine-Associated Receptor 1 Agonists As Narcolepsy Therapeutics
- Label for Adderall
- Dissociable Antidepressant-Like and Abuse-Related Effects of the Noncompetitive NMDA Receptor Antagonists Ketamine and MK-801 in Rats
- Fluorescence-Based Neurotransmitter Transporter Uptake Assay in Primary Neuronal Cultures
- Antidepressants: Serotonin Modulators Medical Policy No
- Should Amphetamines Be Added to SSRI Therapy to Enhance The
- Article Serotonin-Norepinephrine Reuptake Inhibitors And
- Serotonin Reuptake Inhibition by Citalopram in Rat Strains Differing